were quantified at 275 nm. All chalcones (compounds 3, 4, 7 and 8) were detected and quantified at 360 nm. Finally Glycyrrhizin 5 was quantified at 254 nm. The UHPLC-UV chromatogram of G. uralensis crude extract (10 mg/mL) at 254 nm (2 μL injected) is represented on the left.
Kinetex C18-XB (50 x 2.1 mm, 1.7μm) eluted with a gradient composed of (A) H2O + 0.1% formic acid (FA) and (B) ACN + 0.1% (FA) as follows: 8% to 11% B in 2 min, and during 30 sec, to 13% B at 4 min, to 15.5% B at 8 min, to 36% at 13 min, and during 30 sec, to 80% B at 21 min, and during 1 min, back to 8% B at 23 min (flow rate: 0.8 mL/min)
S2. Stacked 1 H NMR profiles of CPC fractions and G. uralensis crude extract
NMR sample of G. uralensis crude extract was prepared by precisely weighing 8 mg followed by the addition of 300 μL of DMSO-d6. From this solution, 200 μL measured with a calibrated pipets (cat no:2-000-200, Drummond Scientific, Broomall, PA, UAS) were added into 3 mm, 7 in. standard NMR tubes. NMR samples of CPC fractions, and purified metabolites were prepared following the same procedure, by precisely weighing 3-5 mg (except for fraction 2: 8mg, fraction 7: 27mg, fractions 10 and 13: 10 mg). The 1D 1 H NMR spectra were acquired at 298 K under quantitative conditions using a 90° single-pulse experiment (DE = 39.71 μsec, D1 = 60.00 sec, P1 = 8.75 μsec, ds = 4, ns = 32, rg = 128) on a Bruker AVANCE 600.13 MHz. Fraction 7 was defined by 21.63 % w/w of glycyrrhizin (5) and contained also phydroxybenzylmalonic acid (9) as well as ononin. Fractions 9 to 11 contained isoliquiritin (3) and neoisoliquiritin (7). Fraction 13 obtained through the extrusion of the stationary phase contained all the non-polar metabolites including liquiritigenin (6) as identified by 1 H NMR analysis.
S3. Stacked UHPLC-UV profiles of CPC fractions and G. uralensis crude extract
The crude extract was prepared at 10 mg/ mL, whereas fraction 1 was analyzed at 2.5 mg/mL. Both solutions were analyzed on a Kinetex C18-XB (50 x 2.1 mm, 1.7μm) and eluted with a gradient composed of (A) H2O + 0.1% formic acid (FA) and (B) ACN + 0.1% (FA) as follows: 8% to 11% B in 2 min, and during 30 sec, to 13% B at 4 min, to 15.5% B at 8 min, to 36% at 13 min, and during 30 sec, to 80% B at 21 min, and during 1 min, back to 8% B at 23 min (flow rate: 0.8 mL/min). Fractions 1 to 3 contained almost no-UV-detectable compounds at 254 nm (except glycyrrhizin in fraction 1). Dept-135 spectra were acquired on a 900 MHz spectrometer, using a RG value of 10300 for all phenolic acids: Phloretic acid (3.86 mg), ns 400; benzylmalonic acid (3.67 mg) ns 400; phydroxybenzylmalonic acid (~2 mg), ns 1000.
S4

S8. HSQC/HMBC spectra of fractions 2 & 7 (600 MHz and 225 MHz, DMSO-d6)
HSQC and HMBC spectra were acquired on a Bruker AVANCE 600.13 MHz, in DMSO-d6 (Cambridge Isotope Laboratories Inc. (Andover, MA, USA). All 13 C NMR spectra were acquired on a Bruker AVANCE 900 MHz spectrometer. Both HSQC and HMBC experiments confirmed the presence of p-hydroxybenzylmalonic acid (9) in fractions 2 to 7. Additionally, the HMBC spectrum of phydroxybenzylmalonic acid was compared with those from each fraction (example with the stacked gHMBC spectra of fraction 7 with HBMA). Even though the proton NMR spectra of 9 in fraction 2 and 7 were slightly different (see S7 and S8), the carbon spectra and HMBC correlations were identical between fractions 2 and 7. S10. PMS file (PERCH NMR software) of p-hydroxybenzylmalonic acid pH4 S11. Semi-preparative chromatograms for the isolation of phydroxybenzylmalonic acid.
Both fractions 2 and 4 were prepared at 100 mg/mL in 50% MeOH HPLC-grade, and 50 µL were injected. The column YMC-Pack-ODS-AQ column (250 ×10 mm, 5 µM) was eluted with a gradient composed of (A) H2O + 0.1% formic acid (FA) and (B) ACN + 0.1% (FA) as follows: from 25% B during 2 min to 40% B in 20 min and during 5 min back to 25% B in 5 min ( flow rate: 2 mL/min). The retention times (tR) were 13.15 min for p-hydroxybenzylmalonic acid (9), and 15.00 min for liquiritin apioside (2). Phloretic acid (0.5 mg/mL) was injected under the same LC conditions and used as a control.
S12. Exemplifying the pH influence on the chemical shifts of p-
hydroxybenzylmalonic acid in fraction 2: comparative 1 H NMR profiles after addition of deuterated acetic acid.
For comparative purposes, the pH of fraction 2 and 7 was roughly estimated with pH strips (Whatman®, panpeha TM ), after diluting 100 μL of the NMR solution into 300 μL of deionized water. In order to exemplify the influence of the pH on the chemical shifts of protons from p-hydroxybenzylmalonic acid, different 1 H NMR spectra were recorded after addition of deuterated acetic acid (acetic acid d4, CAS # 1186-52-3) into fraction 2. The results obtained clearly displayed a gradual down-field shift of the signals from the aromatic protons (Δδ = 0.07 ppm), and from proton H-2 (closest to the carboxylic acids Δδ = 0.50 ppm), whereas the signals from the benzyl protons (H-3) were shifted up-field (Δδ = 0.09 ppm).
S13. Detection and quantification of p-hydroxybenzylmalonic acid in different
Glycyrrhiza extracts (EtOH 95% extracts)
The 1D 1 H NMR spectra were acquired at 298 K under quantitative conditions using a 90° single-pulse experiment (DE = 39.71 μsec, D1 = 60.00 sec, P1 = 8.75 μsec, ds = 4, ns = 18, rg = 256) on a Bruker AVANCE 600.13 MHz. All samples were prepared in 300 µL DMSO-d6. Glycyrrhiza glabra extracts (G.g) Glycyrrhiza inflata (G.i) and Glycyrrhiza uralensis (G.u.) were exactly weighted at 8 mg. Fraction 2 concentrated p-hydroxybenzylmalonic acid (24.56% w/w, 31.8 mM), and had a pH of 6 equivalent to the one measured for the different crude extracts. The pH of isolated p-hydroxybenzylmalonic acid (84 mM) was estimated at ~ 4, the pH of phloretic acid (192 mM) and p-hydroxylphenylacetic acid (189 mM) was found to be 4.5.
The protons signals used for the quantification of p-hydroxybenzylmalonic acid in all extracts were those from the aromatic protons H-3'/5'. The quantification was performed using an internal calibrant IC (3, 5-dinitrobenzoic acid, TraceCERT, Purity 99.54% w/w) at 2.12 mM. clearly confirmed the identity of each major primary metabolite in fraction 1 (supporting information S13 and S14).
G.u-
